Thrombosis
Patients treated for isolated superficial vein thrombosis with anticoagulants still had a "substantial" risk of VTE later on.
Splenomegaly and myeloproliferative disorders increased risk for porto-spleno-mesenteric venous thrombosis after splenectomy.
Edoxaban therapy for 12 months was superior to three-month therapy for preventing venous thromboembolisms and related deaths.
Subclinical leaflet thrombosis appears more common after TAVR versus SAVR, but was not associated with increased stroke risk.
Researchers compared the safety and efficacy of two direct oral anticoagulants (DOACs), apixaban and rivaroxaban, ...
Results from the OCEAN-TAVI registry indicate that a non-antithrombotic strategy may be reasonable following ...
In the second half of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, spoke with ...
In part one of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, sits down with ...
It’s another session of CardioNerds Rounds! In these rounds, Dr. Priya Kothapalli (Interventional FIT at University of ...
DocWire News recently spoke with Dan Bloomfield, MD, FACC, FAHA, Chief Medical Officer of Anthos Therapeutics. Dr. ...
Advertisement
Expert Interviews on Hematology
Advertisement
